Related Experiment Video
Updated: May 9, 2026
13:33
Infinium Assay for Large-scale SNP Genotyping Applications
Published on: November 19, 2013
GStream: improving SNP and CNV coverage on genome-wide association studies
Arnald Alonso1, Sara Marsal, Raül Tortosa
1Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain.
Plos One
|July 12, 2013
Summary
GStream accurately combines genome-wide SNP and CNV genotyping on microarrays, improving variant detection by 25%. This method enhances Genome-Wide Association Studies (GWAS) by identifying copy number variations (CNVs) linked to disease risk.
Area of Science:
- Genomics
- Bioinformatics
- Molecular Biology
Background:
- Accurate genome-wide genotyping of both single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) is crucial for genetic research.
- Existing methods often have limitations in accuracy or combined genotyping capabilities.
- Microarray platforms are widely used but require robust algorithms for comprehensive data analysis.
Purpose of the Study:
- To introduce GStream, a novel method for accurate, combined genome-wide SNP and CNV genotyping on the Illumina microarray platform.
- To demonstrate GStream's superior performance compared to existing genotyping software and CNV calling algorithms.
- To highlight GStream's utility in improving variant detection and enabling new discoveries in Genome-Wide Association Studies (GWAS).
Main Methods:
- Development of the GStream algorithm integrating SNP and CNV genotyping.
- Validation using microarray data from HapMap samples.
- Comparison against reference CNV calls from the 1000 Genomes Project (1KGP) and other established technologies (CGH, genotyping microarrays).
Main Results:
- GStream achieves unprecedented accuracy in combined SNP and CNV genotyping.
- The CNV calling algorithm significantly outperforms state-of-the-art methods, approaching the accuracy of dedicated CNV technologies.
- GStream increases the number of reliably detected variants by up to 25% compared to previous methods.
- Enhanced genome coverage by GStream facilitates the discovery of CNVs in linkage disequilibrium with SNPs associated with disease risk.
Conclusions:
- GStream offers a highly accurate and computationally efficient solution for combined SNP and CNV genotyping.
- The method significantly advances the capabilities of large-scale genetic studies, particularly GWAS.
- GStream provides deeper insights into the genetic architecture of diseases by integrating SNP and CNV data.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...